Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - memantine hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: hyprolose; iron oxide red; iron oxide yellow; microcrystalline cellulose; hypromellose; methylcellulose; magnesium stearate; macrogol 8000; titanium dioxide; croscarmellose sodium - treatment of the symptoms of moderately severe to severe alzheimer's disease (see pharmacology, precautions).

Ireland - English - HPRA (Health Products Regulatory Authority)

as grindeks - memantine hydrochloride - film-coated tablet - 10 milligram(s) - memantine

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - memantine hydrochloride - film-coated tablet - 10 milligram(s) - other anti-dementia drugs; memantine

Malta - English - Medicines Authority

1 a pharma gmbh - memantine hydrochloride 10 mg - film-coated tablet

Malta - English - Medicines Authority

biogaran 15, boulevard charles de gaulle, colombes 92700, france - memantine hydrochloride - film-coated tablet - memantine hydrochloride 10 mg - psychoanaleptics

Singapore - English - HSA (Health Sciences Authority)

novem pharma private limited - memantine 8.31mg eqv memantine hydrochloride - tablet, film coated - memantine 8.31mg eqv memantine hydrochloride 10 mg

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - memantine hydrochloride - tablet, film coated - memantine hydrochloride 10mg

United States - English - NLM (National Library of Medicine)

jubilant cadista pharmaceuticals inc. - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride tablets, usp are indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. pregnancy category b there are no adequate and well-controlled studies of memantine in pregnant women. memantine hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. memantine given orally to pregnant rats and pregnant rabbits during the period of organogenesis was not teratogenic up to the highest doses tested (18 mg/kg/day in rats and 30 mg/kg/day in rabbits, which are 9 and 30 times, respectively, the maximum recommended human dose [mrhd] on a mg/m2  basis). slight maternal toxicity, decreased pup weights and an increased incidence of non-ossified cervical vertebrae were seen at an oral dose of 18 mg/kg/day in a study in which rats were given oral memantine

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; lactose monohydrate; croscarmellose sodium; titanium dioxide; hyprolose; microcrystalline cellulose; macrogol 8000 - treatment of the symptoms of moderately severe to severe alzheimer's disease

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease.